stock-detail (BLCM)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/24/2017 12:17 pm

4/21/2017 06:17 am

4/21/2017 06:17 am

4/21/2017 06:17 am

4/21/2017 06:17 am

4/21/2017 06:17 am

4/11/2017 06:17 am

4/11/2017 06:17 am

4/11/2017 06:17 am

4/11/2017 06:17 am

Bellicum Pharmaceuticals Announces Closing of Public Offering

3/30/2017 11:00 am

[GlobeNewswire] - HOUSTON, March 30, 2017-- Bellicum Pharmaceuticals, Inc. today announced the closing, on March 29, 2017, of its previously announced underwritten public offering of 5,750,000 shares of its common stock, ...

Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock

3/23/2017 10:02 pm

[GlobeNewswire] - HOUSTON, March 23, 2017-- Bellicum Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $12.00 per share. ...

Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock

3/22/2017 08:00 pm

[GlobeNewswire] - HOUSTON, March 22, 2017-- Bellicum Pharmaceuticals, Inc. today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. Bellicum expects to grant the underwriters ...